About Truemeds
Truemeds is a company based in Mumbai (India) founded in 2019 by Akshat Nayyar and Kunal Wani. Truemeds has raised $112.97 million across 6 funding rounds from investors including Accel, Allana and WestBridge Capital. The company has 286 employees as of March 27, 2024. Truemeds offers products and services including Medicine Delivery App, Personal Care Products, Health Supplements, Diabetes Care Items, and Healthcare Devices. Truemeds operates in a competitive market with competitors including Tata 1mg, Netmeds, PharmEasy, MedPlus and SastaSundar, among others.
- Headquarter Mumbai, India
- Employees 286 as on 27 Mar, 2024
- Founders Akshat Nayyar, Kunal Wani
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Intellihealth Solutions Private Limited
- Date of Incorporation 01 Feb, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$6.43 M (USD)395.83as on Mar 31, 2022
-
Net Profit
-$1.85 M (USD)-529.71as on Mar 31, 2022
-
EBITDA
-$3.34 M (USD)-710.1as on Mar 31, 2022
-
Total Equity Funding
$112.97 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jul 16, 2025
-
Investors
Accel
& 57 more
-
Employee Count
286
as on Mar 27, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Truemeds
Truemeds offers a comprehensive portfolio of products and services, including Medicine Delivery App, Personal Care Products, Health Supplements, Diabetes Care Items, and Healthcare Devices.
App for ordering and delivering medicines quickly.
Online store for skin and hair care items.
Platform for vitamins and supplements ordering.
Tools for monitoring and managing diabetes.
Devices for home health monitoring and support.
People of Truemeds
Unlock access to complete
Funding Insights of Truemeds
Truemeds has successfully raised a total of $112.97M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $20.0M
-
First Round
First Round
(16 May 2020)
- Investors Count 58
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series C - Truemeds | Valuation |
investors |
|
| Mar, 2025 | Amount | Series C - Truemeds | Valuation | Accel | |
| Sep, 2023 | Amount | Series B - Truemeds | Valuation | WestBridge Capital , Info Edge Ventures |
Investors in Truemeds
Truemeds has secured backing from 58 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Accel, Allana and WestBridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Accel is recognized as a leading venture capital firm.
|
Founded Year | Domain | Location | |
|
Investment firm focusing on purpose-driven capital for Indian entrepreneurs in sectors like financial services and technology.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Info Edge and Temasek
|
Founded Year | Domain | Location |
Investments & Acquisitions by Truemeds
Financial Statements - Truemeds
Truemeds Comparisons
Competitors of Truemeds
Truemeds operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tata 1mg, Netmeds, PharmEasy, MedPlus and SastaSundar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of an online pharmacy with doctor listing and teleconsultation services
|
|
| domain | founded_year | HQ Location |
Provider of an online store for medicines and healthcare products
|
|
| domain | founded_year | HQ Location |
Provider of an online pharmacy and healthcare platforms
|
|
| domain | founded_year | HQ Location |
Medicines and health products are retailed through pharmacy outlets.
|
|
| domain | founded_year | HQ Location |
An online marketplace for healthcare products is operated.
|
Frequently Asked Questions about Truemeds
Truemeds was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Truemeds is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Truemeds is a funded company, having raised a total of $112.97M across 6 funding rounds to date. The company's 1st funding round was a Series B of $21.28M, raised on May 16, 2020.
As of Mar 27, 2024, the latest employee count at Truemeds is 286.
Annual revenue of Truemeds is $6.43M as on Mar 31, 2022.
Provider of an online pharmacy and telehealth platform. The platform offers a wide selection of medications and personal care products. It facilitates online ordering with prescription uploads, and features a proprietary algorithm suggesting cost-effective substitute medications with equivalent active ingredients from manufacturers. The services include doctor consultations and home deliveries.
Truemeds's top competitors include Tata 1mg, SastaSundar and PharmEasy.
Truemeds offers Medicine Delivery App, Personal Care Products, Health Supplements, Diabetes Care Items, and Healthcare Devices.
Truemeds has 58 investors. Key investors include Accel, Allana, WestBridge Capital, Peak XV Partners, and JM Financial.
The valuation of Truemeds is $132.37M as of Sep 2023.